MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 63 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,485 | -83.5% | 34,503 | -40.5% | 0.00% | – |
| Q1 2023 | $27,243 | -73.4% | 57,963 | -71.7% | 0.00% | – |
| Q4 2022 | $102,543 | +20.6% | 205,086 | +53.5% | 0.00% | – |
| Q3 2022 | $85,000 | -34.1% | 133,596 | -17.9% | 0.00% | – |
| Q2 2022 | $129,000 | +975.0% | 162,730 | +949.1% | 0.00% | – |
| Q1 2022 | $12,000 | -94.3% | 15,511 | -90.4% | 0.00% | – |
| Q3 2021 | $211,000 | +1010.5% | 162,141 | +567.4% | 0.00% | – |
| Q2 2021 | $19,000 | -24.0% | 24,294 | +3.0% | 0.00% | – |
| Q1 2021 | $25,000 | -28.6% | 23,595 | -7.0% | 0.00% | – |
| Q4 2020 | $35,000 | -82.4% | 25,383 | -90.2% | 0.00% | – |
| Q2 2020 | $199,000 | +53.1% | 257,888 | +18.7% | 0.00% | – |
| Q1 2020 | $130,000 | +319.4% | 217,249 | +493.8% | 0.00% | – |
| Q2 2019 | $31,000 | -31.1% | 36,589 | -11.7% | 0.00% | – |
| Q1 2019 | $45,000 | +400.0% | 41,452 | +190.1% | 0.00% | – |
| Q4 2018 | $9,000 | -25.0% | 14,287 | -48.2% | 0.00% | – |
| Q2 2018 | $12,000 | – | 27,593 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alliance Wealth Management Group | 400,826 | $465,000 | 0.23% |
| Yellowstone Partners, LLC | 143,914 | $167,000 | 0.09% |
| IFP Advisors, Inc | 251,172 | $291,000 | 0.01% |
| HYMAN CHARLES D | 79,800 | $93,000 | 0.01% |
| Virtu Financial LLC | 106,146 | $123,000 | 0.01% |
| Raymond James Financial Services Advisors, Inc. | 659,890 | $765,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 21,181 | $25,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 189,000 | $219,000 | 0.00% |
| BlackRock Inc. | 2,530,508 | $2,935,000 | 0.00% |
| Bank of New York Mellon Corp | 175,325 | $203,000 | 0.00% |